公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 GRIFOLS BRASIL LTDA取消

154 记录

产品持有公司班级有效性
Anti-Human Globulin Mono-Type (green)80134860296GRIFOLS BRASIL LTDAIII02/10/2033
Sero-Cyte Pool Diª 0.8%80134860291GRIFOLS BRASIL LTDAIII26/06/2033
Anti-Fyb Mono-Type Dual80134860292GRIFOLS BRASIL LTDAIV26/06/2033
Procleix Plasmodium Assay80134860289GRIFOLS BRASIL LTDAIV05/06/2033
Data-Cyte Extend 0.8%80134860284GRIFOLS BRASIL LTDAIII08/08/2032
Diego(a)-Cyte 0.8%80134860280GRIFOLS BRASIL LTDAIII06/09/2031
Data-Cyte Plus P 0.8%80134860279GRIFOLS BRASIL LTDAIII30/08/2031
Screen-Cyte P 0.8%80134860274GRIFOLS BRASIL LTDAIII22/03/2031
Família Reverse-Cyte® 5%80134860273GRIFOLS BRASIL LTDAIV28/12/2030
Família Anti-Lea for DG Gel e Anti-Leb for DG Gel80134860272GRIFOLS BRASIL LTDAIII15/06/2030
Anti-Lua for DG Gel80134860271GRIFOLS BRASIL LTDAIII02/12/2029
Anti-Cw Mono-Type Dual80134860268GRIFOLS BRASIL LTDAIII25/11/2029
Reverse-Cyte 0.8%80134860269GRIFOLS BRASIL LTDAIV25/11/2029
Anti-Lub Mono-Type Dual80134860270GRIFOLS BRASIL LTDAIII25/11/2029
Procleix Zika Vírus80134860266GRIFOLS BRASIL LTDAIV30/09/2029
Anti-M Mono-Type Dual e Anti-N (LN3/MN879) Mono-Type80134860264GRIFOLS BRASIL LTDAIII02/09/2029
Anti-S Mono-Type e Anti-s Mono-Type80134860265GRIFOLS BRASIL LTDAIII02/09/2029
Família Anti-Kpa Dual e Anti-Kpb Dual80134860261GRIFOLS BRASIL LTDAIV03/06/2029
Anti-P1 Mono-Type Dual80134860262GRIFOLS BRASIL LTDAIII03/06/2029
DG Gel ABO/Rh (2D)(RT)80134860259GRIFOLS BRASIL LTDAIV13/12/2028
Anti-K Mono-Type (2)80134860251GRIFOLS BRASIL LTDAIV26/02/2028
Data-Cyte® Plus 0.8%80134860250GRIFOLS BRASIL LTDAIII17/07/2027
Anti-K (Cellano) Mono-Type80134860243GRIFOLS BRASIL LTDAIV10/07/2027
Anti-Fya Mono-Type80134860244GRIFOLS BRASIL LTDAIV10/07/2027
Anti-H Mono-Type80134860245GRIFOLS BRASIL LTDAIV10/07/2027

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家